{"organizations": [], "uuid": "223c26841550ca90bb17d4744e63b37a68cc0272", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/02/26/the-associated-press-exelixis-meets-4q-profit-forecasts.html", "country": "US", "domain_rank": 767, "title": "Exelixis meets 4Q profit forecasts", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-27T00:12:00.000+02:00", "replies_count": 0, "uuid": "223c26841550ca90bb17d4744e63b37a68cc0272"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/02/26/the-associated-press-exelixis-meets-4q-profit-forecasts.html", "ord_in_thread": 0, "title": "Exelixis meets 4Q profit forecasts", "locations": [], "entities": {"persons": [], "locations": [{"name": "south san francisco", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "south san francisco", "sentiment": "none"}], "organizations": [{"name": "exel", "sentiment": "negative"}, {"name": "exelixis inc.", "sentiment": "negative"}, {"name": "exelixis", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SOUTH SAN FRANCISCO, Calif. (AP) _ Exelixis Inc. (EXEL) on Monday reported fourth-quarter net income of $38.5 million.\nOn a per-share basis, the South San Francisco, California-based company said it had net income of 12 cents.\nThe results matched Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was also for earnings of 12 cents per share.\nThe drug developer posted revenue of $120.1 million in the period, exceeding Street forecasts. Six analysts surveyed by Zacks expected $118.2 million.\nFor the year, the company reported net income of $154.2 million, or 49 cents per share, swinging to a profit in the period. Revenue was reported as $452.5 million.\nExelixis shares have dropped nearly 3 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $29.53, a climb of 36 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on EXEL at https://www.zacks.com/ap/EXEL", "external_links": [], "published": "2018-02-27T00:12:00.000+02:00", "crawled": "2018-02-27T01:01:39.031+02:00", "highlightTitle": ""}